drugset / Trial / NCT00002639

Suramin in Treating Patients With Recurrent Primary Brain Tumors

NCT00002639

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of suramin in treating patients with recurrent primary brain tumors following radiation therapy.

Timeline

Start
1995-07
Primary completion
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Subject suramin Small molecule

Indications